宇環數控(002903.SZ)一季度預盈2000萬-2500萬元 同比扭虧為盈
格隆匯 3 月 29日丨宇環數控(002903.SZ)公佈,預計2021年度第一季度歸屬於上市公司股東的淨利潤2000萬元-2500萬元,上年同期虧損421.91萬元。
報吿期內,公司努力推進重大合同的執行,全面完成訂單交付和驗收;同時公司充分發揮在研磨拋光領域的優勢,緊跟市場需求,加大技術創新和投入,新產品逐步投放市場,公司主營業務收入較去年同期實現較大幅度增長。
公司積極承擔和推進重大技術專項和項目建設,報吿期內收到的政府補助金額較去年同期增加,預計公司2021年第一季度非經常性損益影響當期歸屬於上市公司股東的淨利潤在710萬元-760萬元之間
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.